Relay Therapeutics, Inc. (RLAY): A Bull Case Theory
We came across a bullish thesis on Relay Therapeutics, Inc. (RLAY) on Substack by Steve Wagner. In this article, we will summarize the bulls’ thesis on RLAY. Relay Therapeutics, Inc.
Relay Therapeutics Inc. (RLAY)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period: Filing is Ongoing
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | BIT Capital GmbH Jan Beckers | 0 | $0 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $20.00 | 25,000 | Officer, Director | 403,082 | 2020-07-20 | Filing | |
| $20.00 | 25,000 | Director | 1,021,952 | 2020-07-20 | Filing | |
| $20.00 | 25,000 | Director | 25,000 | 2020-07-20 | Filing | |
| $20.00 | 25,000 | Director | 25,000 | 2020-07-20 | Filing | |
| $20.00 | 10,000 | Officer | 10,000 | 2020-07-20 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $3.00 | 10,739 | 390,081 | 2025-04-30 | Filing | ||
| $3.17 | 1,364 | 400,820 | 2025-04-28 | Filing | ||
| $3.00 | 12,943 | 355,376 | 2025-04-30 | Filing | ||
| $3.23 | 3,558 | 368,319 | 2025-04-29 | Filing | ||
| $3.17 | 981 | 371,877 | 2025-04-28 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 14,478,798 | $37,934,451 | 0% | |
| 2. | 12,105,420 | $31,716,201 | 0% | |
| 3. | 2,077,995 | $5,444,347 | 0% | |
| 4. | 1,568,753 | $4,110,133 | 0.26% | |
| 5. | 1,064,858 | $2,789,928 | 0% |
News See All
11 Most Promising Penny Stocks According to Analysts
Solus’ Dan Greenhaus, and Invesco's Brian Levitt together appeared on CNBC's 'Closing Bell' on April 15 to talk about tariffs, market uncertainty, and risk concerns.
13 Best Biotech Penny Stocks to Buy According to Hedge Funds
Peter Marks's departure from the FDA has left innovators concerned regarding the current state of the review program at the FDA. Marks had impacts on two key areas.
10 Stocks Under $10 that Will Triple
As we delve into the discussion on stocks that will triple, we must shed light on the U.S.
Top 9 AI Ratings and News Updates on Wall Street’s Radar
Despite AI's potential to transform our lives for the better, security threats associated with the technology continue to make headlines.
Top 10 Medical AI Stocks on Wall Street's Radar
Investments in the global healthcare industry have ramped up sharply since the COVID-19 pandemic.
12 Best Biotech Penny Stocks To Invest In Now
Goldman Sachs has spotlighted an often-overlooked sector poised to benefit from lower borrowing costs: biotechnology stocks.
Relay Therapeutics, Inc. (RLAY): A Bull Case Theory
We came across a bullish thesis on Relay Therapeutics, Inc. (RLAY) on Substack by Steve Wagner | Invest. In this article, we will summarize the bulls’ thesis on RLAY. Relay Therapeutics, Inc.
10 Best All-Time Low Stocks To Buy Right Now
With November coming to a close, while markets are focused on the future of artificial intelligence and the degree of profitability that AI firms can extract from their multi-billion dollar investments...
11 Oversold Biotech Stocks To Buy Right Now
In this article, we will be taking a look at 11 oversold biotech stocks to buy right now.
Billionaire Hedge Funds
